Pre‐emptive treatment of recurrent hepatitis C infection

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Liver transplantation

• Publication date

  2002-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/JLTS.2002.35859PMID 12362299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of Hepatitis C

  2018cited by this paper
• The association between hepatitis C infection and survival after orthotopic liver transplantation.

  2002cited by this paper
• A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantation

  2002cited by this paper
• Therapy for acute hepatitis C.

  2001cited by this paper
• Combination of interferon induction therapy and ribavirin in chronic hepatitis C

  2001cited by this paper
• Treatment of acute hepatitis C with interferon alfa-2b.

  2001cited by this paper
• Early treatment of acute hepatitis C infection may lead to cure.

  2001cited by this paper
• Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt.

  2000cited by this paper
• Successful rescue of severe recurrent hepatitis C with interferon and ribavirin in a liver transplant patient.

  2000cited by this paper
• Liver transplantation for chronic viral hepatitis.

  1999cited by this paper
• Treatment of acute hepatitis C virus infection.

  1999cited by this paper
• Recurrent and new hepatitis C virus infection after liver transplantation

  1999cited by this paper
• High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes

  1999cited by this paper
• Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection

  1998cited by this paper
• The efficacy of prophylactic interferon alfa‐2b in preventing recurrent hepatitis C after liver transplantation

  1998cited by this paper
• Liver transplantation in hepatitis C. A Spanish multi‐centre experience

  1998cited by this paper
• The influence of hepatitis C virus genotypes on the outcome of liver transplantation.

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin.

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Predictors of patient and graft survival following liver transplantation for hepatitis C

  1998cited by this paper
• Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation

  1998cited by this paper
• A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

  1998cited by this paper
• Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury.

  1998cited by this paper
• Long‐term outcome of hepatitis C virus infection after liver transplantation

  1997cited by this paper
• Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

  1997cited by this paper
• Causes of graft loss following liver transplantation for chronic hepatitis C.

  1997cited by this paper
• Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.

  1997cited by this paper
• Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation

  1997cited by this paper
• Epidemiology of hepatitis C

  1997cited by this paper
• Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia

  1996cited by this paper
• Demographic determinants of hepatitis C virus seroprevalence among blood donors.

  1996cited by this paper
• Graft loss following liver transplantation in patients with chronic hepatitis C.

  1996cited by this paper
• Long-term outcome of hepatitis C infection after liver transplantation.

  1996cited by this paper
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection

  1995cited by this paper
• Alpha-interferon for acute hepatitis C in liver transplant patients.

  1995cited by this paper
• Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features

  1995cited by this paper
• Liver transplantation for hepatitis C virus‐related cirrhosis

  1994cited by this paper
• Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients.

  1994cited by this paper
• The course of hepatitis C virus infection after liver transplantation

  1994cited by this paper
• Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.

  1994cited by this paper
• Interferon‐α therapy for hepatitis c virus infection after liver transplantation

  1994cited by this paper
• Recurrent and acquired hepatitis C viral infection in liver transplant recipients.

  1992cited by this paper
• Reinfection of liver graft by hepatitis C virus after liver transplantation.

  1992cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper

• Tratamiento de la hepatitis C en el pre- y postrasplante hepático

  2016cites this paper
• [Treatment of hepatitis C before and after liver transplantation].

  2016cites this paper
• Hepatitis C treatment for patients post liver transplant

  2015cites this paper
• Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.

  2013cites this paper
• Treatment of Hepatitis C in Solid Organ Transplantation

  2012cites this paper
• Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation.

  2010cites this paper
• How should we treat recurrent hepatitis C after liver transplantation?

  2005cites this paper
• Outcome and management of hepatitis C in liver transplant recipients.

  2003cites this paper